Skip to content

Introducing

Tiger Eye
India Cell

EXPECTED ANNUAL
RETURN: >10%

Why India?

Stock Market

  • 4th Largest

  • Surged Past UK & France

Economy

  • Fastest Growing 6.0% – 7.0%

  • To become 3rd Largest by 2035

Multinationals Shift

  • India Over China

  • Goldman Sach, JP Morgan, Morgan Stanley, Apple

Governance

  • Broad policy continuity

  • Make in IndiaIncrease in FDI

Introducing your gateway to high-potential Indian companies. With a focus on rigorous research and strategic investments, we offer a dynamic opportunity to capitalize on India’s thriving economy.

Flagship Funds

Amethyst Conservative Cell

EXPECTED ANNUAL RETURN: >6%

Enjoy steady returns while preserving your hard-earned capital with our conservative strategy. Our expertly managed fund aims to outperform fixed term deposits over the long run.

Data as at June 2024 – to be updated on a quarterly basis

Data as at June 2024 – to be updated on a quarterly basis

Data as at June 2024 – to be updated on a quarterly basis

Citrine ESG Cell

EXPECTED ANNUAL RETURN: >8%

Join the league of smart investors who not only benefit from the solid performance of Blue Chip ESG Companies but also contribute to a better world by supporting socially responsible practices.

Data as at June 2024 – to be updated on a quarterly basis

Data as at June 2024 – to be updated on a quarterly basis

Aventurine Alternatives Cell

EXPECTED ANNUAL RETURN: >12%

Invest in our alternative fund for a unique opportunity to diversify your portfolio with non-traditional investments, potentially generating higher returns while minimizing risk through curated investment strategies.

Data as at June 2024 – to be updated on a quarterly basis

Data as at June 2024 – to be updated on a quarterly basis

Data as at June 2024 – to be updated on a quarterly basis

Talk to us today!

Book a meeting with us and let's talk about investment. The team shall gladly and assist you. 

Contact us now!

Contact Form Demo (#7)

Book a free consultation with us!

Contact Form Demo (#7)